RENOWN NEWSROOM

Clinical researchers with the Healthy Nevada Project co-author research paper with findings that emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  Breast cancer is a leading cause of cancer death among women in the United States. According to the American Cancer Society, about 1 in 8 women will develop breast cancer and about 1 in 39 women will die from breast cancer. Breast cancer is associated with increased age, hereditary factors, obesity, and alcohol use. Since 1990, breast cancer death rates have declined progressively due to advancements in treatment and detection. In Nevada there are an estimated 2,310 new breast cancer cases a year, and genetic mutations such as in the genes BRCA1 or BRCA2 remain a top risk factor for this prevalent disease. Recognizing the urgency for progress in breast cancer research, a collaborative effort between physicians, advanced practice providers and scientists from the Healthy Nevada Project® (HNP) and Helix have unveiled groundbreaking research. This study explores how genetic screenings are a necessary supplement to traditional testing methods, together offering more accurate insights into a patient's likelihood of developing breast cancer in the future. HNP is operated by Renown Genomic Medicine and the Institute for Health Innovation and is one of the largest community-based population health studies in the country. Their team works in collaboration with Helix, a leader in precision health that delivers comprehensive genomic solutions. Together, this dynamic partnership aims to understand breast cancer risk factors and pave the way for more effective preventative measures. The combined research team studied 25,591 female HNP participants to evaluate the performance of different genetic screening approaches to identify women at high risk of breast cancer. The results of this research suggest that a combined monogenic, or single-gene, and polygenic, or multi-gene, approach to breast cancer screenings helped produce more accurate results and more closely identify study participants who have a high genetic risk of developing the disease. "Based on this research, we are advocating a shift in approach which would improve breast cancer risk assessment through a combination of effective family history ascertainment and genetic screening,” said Joseph Grzymski, PhD, principal investigator of the Healthy Nevada Project, research professor at the University of Nevada, Reno School of Medicine and co-author of the breast cancer research paper. “This tailored approach, founded on the assessment of individual genetic risk, not only intends to elevate patient well-being but also will improve efficiency and equity in healthcare." Complementing the team’s research on leveraging genetics to identify women at low genetic risk of breast cancer that could safely defer mammogram screenings by five to 10 years that was released in late 2023 in JAMA Oncology, the study suggests that incorporating genetic information can assist in personalizing breast cancer screenings and optimizing the use of screening resources. "Existing disparities persist across various facets of breast cancer screening and treatment; however, genetic screening is clearly a powerful tool to help facilitate early intervention for those at higher risk,” said Jamie Schnell Blitstein, APRN, a primary care nurse practitioner at Renown Health and co-author of the breast cancer research paper. “By placing a heightened focus on risk, we underscore the pivotal role of preventative breast cancer screening.” Despite the availability of effective methods for early screening, co-authors of this research found that 78 percent of women with a family history of breast cancer had their risk ascertained only after a breast cancer diagnosis. The findings emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  “These findings that can profoundly impact how healthcare is delivered were only made possible by all the participants who were willing to consent to research,” said Alex Bolze, PhD from Helix and co-author of the publication. “Broad-scale collaboration projects like these between Renown Health and UNR that engage large populations where participants share both their genetic information as well as electronic health records drive advancements in preventative medicine, as well as fundamental biological research.”   The research paper was officially accepted on Jan. 29, 2024, and will be published by Elsevier, Inc. on behalf of the American College of Medical Genetics and Genomics. The contents of the paper will appear in the international journal Genetics in Medicine Open. Read the full article by visiting sciencedirect.com. The Healthy Nevada Project is currently recruiting new study participants. Free to all Nevadans with a saliva sample or blood draw, participants and their referring providers receive access to whole-exome sequencing and clinical grade results that help provide insight into their unique genetic risks tied to heart disease and certain cancers. If you are interested in enrolling in the study, schedule a Virtual Consent Appointment through MyChart or contact the Renown Institute for Health Innovation at RenownIHI@renown.org or (775) 982-6914 to be connected to a Genomic Representative. About Renown Health Renown Health is the region’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the largest community-based genetic population health study, the Healthy Nevada Project®. To join the Renown Health team, visit renown.org/careers. About Helix Helix is the leading population genomics and viral surveillance company operating at the intersection of clinical care, research, and data analytics. Helix enables health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision-making. Learn more at helix.com.

Read More About Research Shows Genetic Approaches to Breast Cancer Screenings Yield More Accurate Results

Renown Health is pleased to announce that Kate A. Ward, Pharm.D., BCPS, has been promoted to serve as Vice President, Oncology for Renown Regional Medical Center.    Dr. Ward has over fourteen years of service to the organization, most recently as Director of Clinical Pharmacy responsible for the oversight of all clinical pharmacy activities at Renown Regional Medical Center, Renown South Meadows Medical Center, and Renown Rehabilitation Hospital. Additionally, Dr. Ward is the Residency Director of the Post-Graduate Year 1 (PGY1) Pharmacy Practice Residency at Renown. Over the last decade at Renown, Dr. Ward has served as Pharmacy Clinical Manager, Pharmacy Clinical Coordinator and Clinical Pharmacist.   Dr. Ward will bring her pharmacy clinical service experience (including ICU, Outpatient Infusion, Pediatrics, Oncology and Emergency Services), Inpatient Care, Clinical Research, and Hospital Formulary Management, Electronic Medical Record Integration and Optimization to this important new role.   As a dyad partner with Max J. Coppes, MD, PhD, MBA, Director of the William N. Pennington Cancer Institute at Renown, she will bring her clinical, operational, regulatory, and administrative experience to lead the oncology division. Dr. Ward, Dr. Coppes and the dedicated team will advance Renown’s mission to expand care, prevention, screening, research, and education with the goal of establishing the first National Institutes of Health, NCI designated Cancer Center for our State.   “We are thrilled to welcome Dr. Ward as our new Vice President of Oncology. She brings a wealth of experience and a passion for advancing patient care. Dr. Ward will play a pivotal role in sharing the future our oncology division and furthering our commitment to providing exceptional care,” said Chris Nicholas, CEO of Renown Regional Medical Center.    As a licensed pharmacist, Dr. Ward holds a Doctor of Pharmacy degree from the University of Colorado, Health Sciences Center. The Pharm.D. is a professional degree like a Doctor of Medicine (MD) or Doctor of Dental Surgery (DDS). As a doctorate, it represents the increasing responsibility pharmacists have in healthcare systems and the high trust Americans have in pharmacists.    Dr. Ward completed her residency at Stanford Hospital and Clinics. She graduated from the University of Nevada, Reno with her bachelor’s degree in Nutritional Sciences. Dr. Ward is active in several professional associations and currently serves as a Pharmacy Board member for HealthTrust; Vice Chair of the American Society of Health System Pharmacists® Council on Therapeutics; and Vice Chair for the Silver State Scripts Board for the State of Nevada. Dr. Ward was the 2022 recipient of the Nevada Society of Health System Pharmacists (NVSHP) President’s Award. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. To join the Renown Health team, visit renown.org/careers.

Read More About Exceptional Talent Joins William N. Pennington Cancer Institute at Renown; Dr. Kate Ward Brings Expertise and Vision as Vice President of Oncology Division

Renown Medical Group is thrilled to welcome two distinguished breast surgical oncologists, Colleen O'Kelly-Priddy, MD and Michelle K. Chu, MD to the team. These highly skilled breast surgeons will solely focus on providing breast care and therefore play a pivotal role in Renown Health’s William N. Pennington Cancer Institute’s commitment to provide subspecialized care to the people living in our community and beyond. Dr. Colleen O'Kelly-Priddy is a fellowship-trained, board-certified breast surgical oncologist with an impressive background in breast cancer surgery. Dr. Priddy was born at Washoe Medical Center (which later became Renown Regional Medical Center) and grew up in Susanville, CA before attending Stanford University for her undergraduate studies. She is a graduate of the University of Nevada, Reno School of Medicine. "I am thrilled to return to Reno to help increase access to world-class surgical breast cancer care,” said Dr. Priddy. “My focus is to provide exceptional care, particularly for young people with breast cancer. I am excited to continue my mission here in northern Nevada." Dr. Michelle K. Chu, a board-certified general surgeon, brings her extensive experience in advanced breast cancer treatment to the Renown team. Dr. Chu received her undergraduate degree from the University of Pennsylvania and her medical degree from Western Reserve School of Medicine in Cleveland, OH. Dr. Chu specializes in oncoplastic breast conserving surgery and nipple sparing mastectomies. "I believe in tailoring treatment options to each patient's unique needs,” Dr. Chu said. “Whether it's preserving the natural shape of the breast or supporting the 'Going Flat' movement, our team strives to provide the best possible outcome for every patient." The newest addition to the William N. Pennington Cancer Institute, Renown Breast Surgery Care provides comprehensive breast surgery care at 1500 E. 2nd Street in Reno, adjacent to the Renown Regional Medical Center campus. "Breast cancer accounts for approximately 20% of newly diagnosed cancer cases in Washoe County, with roughly 520 new cases annually, establishing it as the most prevalent cancer type within our community,” says Brian Erling, MD, MBA, President & CEO, Renown Health. “We are proud, as the community’s largest not-for-profit healthcare system, to invest in cancer prevention and early diagnoses, including mammography screening and genetic research. For those diagnosed with breast cancer, Renown now offers two superb breast surgeons specializing in breast preservation surgery, and a breast surgery center providing comprehensive, compassionate care. Our goal is to save women’s lives, save families and ensure better care and better outcomes. This is a major step forward for women’s healthcare and our community.” As part of this expansion, Renown is assuming operations of Reno Surgical Advocates, a respected private practice in Reno. "Access to expert breast cancer care close to home is crucial, and our dedicated team at Renown Breast Surgery Care will work tirelessly to provide the highest level of care to patients while working closely with our other cancer specialists," said Max Coppes, MD, PhD, MBA, Director, William N. Pennington Institute for Cancer. “With the exceptional expertise of Dr. Colleen O'Kelly-Priddy and Dr. Michelle K. Chu, coupled with our state-of-the-art facility; Renown Health is a true partner in the fight against breast cancer in northern Nevada.” "People are increasingly relocating to northern Nevada, and in fact, Washoe County experienced a 2.1% population growth from April 2020 to July 2022. Consequently, although northern Nevada does not exhibit an above-average cancer rate, we are observing a rise in cases at our facilities," said Dr. Lee Schwartzberg, MD, FACP, Section Chief of Medical Oncology at the William N. Pennington Cancer Institute. "Renown Health is positioned to meet this growing demand, and we take pride in consistently adding nationally renowned healthcare providers to our team to save the lives of women in northern Nevada.     About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health.

Read More About Saving More Lives; Renown Expands Breast Cancer Care, Adding Two Best-In-Class Breast Surgeons

Recognized as one of the world’s leading breast cancer experts as a 2023 Legends in Cancer Honoree Dr. Lee Schwartzberg, FACP, Section Chief of Medical Oncology at the William N. Pennington Cancer Institute at Renown, was honored as the 2023 Legends in Cancer honoree at this year's Best of Breast conference for his contributions to the field of breast cancer. The conference took place on Jan. 21 and 22. Breast cancer is a leading cause of cancer death among women in the United States. According to the American Cancer Society, about 1 in 8 women will develop breast cancer and about 1 in 36 women will die from breast cancer. Breast cancer is associated with increased age, hereditary factors, obesity, and alcohol use. Since 1990, breast cancer death rates across the country, and here in Washoe County have declined progressively due to advancements in treatment, detection, and care. Each year in the United States, about 264,000 cases of breast cancer are diagnosed in women and about 2,400 in men. Here in Washoe County, more than 21 deaths per 100,000 females are due to breast cancer, a significant decrease since 2012 when 24 deaths per 100,000 females were reported. Dr. Schwartzberg was selected for this award based on his unique and vast contributions to advancing science and patient care, including his major research interests such as therapeutic approaches to breast cancer, targeted therapies, and supportive care. The selection committee evaluates each candidates’ body of work — including contributions to the field of breast cancer in clinical research, patient care, mentoring and community service — before deciding on an honoree. “Dr. Schwartzberg is deserving of this honor. As a national expert in the study and treatment of breast cancer, precision medicine and supportive care, Dr. Schwartzberg is transforming cancer care and improving the lives of all of us in northern Nevada. As the most preferred cancer program in the region, we are working with the support of donors like The William N. Pennington Foundation to recruit additional oncology specialists and cancer science researchers to become the first National Cancer Institute-designated comprehensive cancer care center in Nevada," said Dr. Brian Erling, MBA, CEO of Renown Health. “The incredible care that comes from the William N. Pennington Cancer Institute is possible because of nationally recognized oncologists like Dr. Schwartzberg.” “Dr. Schwartzberg completed fellowship training in medical oncology and hematology at Memorial Sloan Kettering Cancer Center in New York, where he also served as Chief Medical Resident and was a founding member of the institutional ethics committee,” add Paul J. Hauptman, MD, dean of the University of Nevada, Reno School of Medicine and chief academic officer for Renown Health. “We are proud that he serves as a professor of clinical medicine at the University of Nevada, Reno School of Medicine. His research interests include supportive care, precision medicine and patient-reported outcomes in breast cancer and he has published over 300 peer-reviewed manuscripts, book chapters and monographs.” “It is an honor to work with Dr. Schwartzberg and his patients have the most incredible things to say about the care he provides.” said Dr. Max J Coppes, PhD, MBA, Director, William N. Pennington Cancer Institute, Renown Health. “He understands that his patients are going through one of the most challenging times in their lives. Dr. Schwartzberg brings decades of experience to our community, is a great listener, and treats everyone with compassion and dignity. We are so proud to have him at Renown.” The Best of Breast Conference is an innovative medical education program that gathers the world's leading breast cancer experts to discuss cases with high-risk characteristics, adjuvant and metastatic treatment advances, interdisciplinary care and survivorship and recurrence — all while incorporating data from the major oncologic annual meetings. Dr. Schwartzberg has been selected to chair Total Health’s spring oncology education retreat in Lake Tahoe on April 15 and 16. The event’s comprehensive agenda will allow attendees to engage with the latest research and strategies in cancer care while networking with colleagues from across the country in a peaceful setting. Additional conference information is available here. For women, breast exams using mammography after 40 years old is recommended. For those age 75 and older, a mammogram is recommended every year. Having regular mammograms can lower the risk of dying from breast cancer. Both 3-D digital mammography and whole breast ultrasounds are available at the Greenberg Breast Health Center at Renown and other locations across northern Nevada. The Affordable Care Act makes breast cancer screening and counseling free. All health plans must cover these benefits at no cost to you. Renown MyChart app users can self-schedule a mammogram appointment. To call to schedule, dial 775-982-8100. At the William N. Pennington Cancer Institute at Renown Health, patients receive innovative, personalized treatment to fight cancer while an experienced team provides the support and technology to maintain the highest quality of life. The Renown team’s clinical expertise and advanced treatment options blend evidence-based care with leading-edge research to improve cancer outcomes for every patient and family. For more information or a referral, visit renown.org/cancer. About Renown Health Renown Health is Nevada’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in a community-based genetic population health study, the Healthy Nevada Project®. About Total Health Total Health is a medical information company of planning experts who produce tailored content, courses, and conferences for oncology healthcare providers, virtual and in-person. Total Health believes knowledge is power. Its mission is to give oncology healthcare providers an educational experience that equips them with the latest strategies to improve clinical practice and treatment outcomes.

Read More About Dr. Lee Schwartzberg Honored With 2023 Legends in Cancer Award

Protecting employees and their families; providing the safest, highest-level of care to patients and supporting public health Renown Health, one of the region’s largest private employers with a work force of almost 7,000, and a not-for-profit integrated healthcare network serving over 1 million people across Nevada, today notified its employees that it will support the national Emergency Regulation and will require COVID-19 vaccination for all Renown Health employees. Communicating to employees today, Tony Slonim, MD, DrPH, President & CEO, wrote, “For the last nineteen months, we have done everything humanly possible to care for patients, our community and each other- and to keep people safe from COVID-19. Despite these efforts, too many people have fallen ill, suffered long-term effects or lost those they loved to this deadly disease.” He added, “I believe that as the leading anchor institution for our community, we are obligated to set a clear example of our trust in data and science, and to hold ourselves to the highest ethical and professional standards to keep our community safe. It is clear that the vaccine is safe and effective in reducing illness and saving lives and we encourage everyone who is medically able to do so, and within their religious guidelines, to get vaccinated.” Dr. Slonim thanked his staff for “heeding the call for vaccination and protecting those in our care who are ill and physically vulnerable, and ensuring a safe, COVID-19-free environment for them and for each other.” As of today, 80% percent of all 6,750 Renown Health employees have already been vaccinated or granted an approved exemption or deferral. On November 4th, The Biden-Harris Administration announced required COVID-19 vaccination of eligible staff at health care facilities that participate in the Medicare and Medicaid programs.The American Hospital Association, American Medical Association and multiple national societies representing medical professionals and at least 174 health care organizations nationally have recommended that vaccination be required for all healthcare personnel as a condition of employment. COVID-19 vaccination prevents serious illness, hospitalization and death. Documented declines in cases since mass vaccination began prove the COVID-19 vaccines are both safe and effective, and are crucial to decreasing the spread of the virus. Renown’s requirement applies to all employees, new hires and students. Chief Medical Officers strongly endorse the mandate. “Our role is to provide the safest, highest-level of care to people who come to us for care, and we must do our part to support public health, which has been greatly enhanced in this state because of the utilization and uptake of the vaccine,” said Rahul Mediwala, MD, CPE, Chief Medical Officer, Health Services. Dr. Mediwala was instrumental in Renown’s volunteer effort to administer 80,000 vaccinations to employees and community members, and now to children ages 5-11 at its Hometown Health location earlier this year. We know that there’s some hesitancy that exists, but the data are clear that these vaccinations have been very effective in preventing hospitalizations, severe complications and deaths from COVID-19,” says Susan Lee, DO, MBA, Chief Medical Officer, Acute Services. “We encourage all colleagues, patients, and community members to receive the COVID-19 vaccine as soon as possible.”   The Biden-Harris Administration requirements will apply to approximately 76,000 providers and cover over 17 million health care workers across the country. The regulation will create a consistent standard within Medicare and Medicaid while giving patients assurance of the vaccination status of those delivering care. Facilities covered by this regulation must establish a policy ensuring all eligible staff have received the first dose of a two-dose COVID-19 vaccine or a one-dose COVID-19 vaccine prior to providing any care, treatment, or other services by December 6, 2021. All eligible staff must have received the necessary shots to be fully vaccinated – either two doses of Pfizer or Moderna or one dose of Johnson & Johnson – by January 4, 2022. The regulation also provides for exemptions based on recognized medical conditions or religious beliefs, observances, or practices. Facilities must develop a similar process or plan for permitting exemptions in alignment with federal law. Renown will do direct outreach to those employees who have not yet been vaccinated, to be sure they understand the regulations, implications, and options available to them. Dr. Slonim closed his announcement to employees today by saying, “While we understand this is a heavy issue for many, the mandate is clear and is one we will abide by. It is the right thing to do for our patients and each other.”   About Renown Health Renown Health is a locally governed, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of almost 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to improve the care and the health of our community. For more information, visit renown.org.

Read More About Renown Health Expands Covid-19 Vaccination Requirement

Renown joins Washoe County Health District to Offer COVID-19 Vaccines to Children 5-11 at Vaccine Clinics. Renown Health is partnering with the Washoe County Health District to help distribute the initially available, limited supplies of an age-appropriate dose of the COVID-19 Pfizer-BioNTech vaccines to children ages 5-11. At this time, all residents 5 years and older are eligible to receive a vaccine. Renown announced today that for parents/guardians with proxy access for their children through the Renown MyChart app, vaccination appointments are now available for children ages 5-11. Pending supply, Renown expects to be able to vaccinate 1,600 children with the 2-dose series in a limited series of weekend clinics. At this time, due to limited supplies, no vaccines for children are available through Renown Medical Group pediatric offices. Vaccine appointments may only be scheduled through the Renown MyChart app; please do not contact a Renown doctor/health care provider or the Engagement Center at this time. There is no cost to establish a Renown MyChart account, and you do not need to have a Renown provider to enroll. For MyChart Technical Support, call 775-982-2781. Renown is covering all costs of the vaccine, and it is offered free of charge. “As a pediatrician, an intensive care physician, a public health practitioner and a grandparent, I encourage parents to vaccinate their children against COVID-19 now. No child should suffer, be hospitalized or die from a disease that can prevented by simply getting a shot,” says Tony Slonim, MD, DrPH, President & CEO of Renown Health. “We remain steadfast in fighting the good fight for our community, and that includes protecting kids. Being able to serve kids and their parents, with the only Children’s Hospital in northern Nevada, and being able to administer COVID-19 vaccines to children is incredibly gratifying for our team. This vaccine will prevent deaths, ICU admissions and will prevent significant long-term adverse outcomes in children." “I tell parents, get your kids vaccinated now- because every kid is at risk,” says Kristina Deeter, M.D., MBA, Pediatric Intensivist, and Vice Chair of Pediatrics at Renown Children’s Hospital. “Please get your family- including your kids, vaccinated now to keep your family safe. Being fully vaccinated and being able to hug Grandma and Grandpa at the holidays may be the greatest gift of all this holiday season.” “The CDC recommends everyone ages 5 and older get a COVID-19 vaccine to help protect against COVID-19. Widespread vaccination for COVID-19 is a critical tool to protect everyone, especially those at highest risk, from severe illness and death. Currently, the Pfizer vaccine is the only option currently authorized for children,” says Vanessa Slots, MD, a pediatrician with Renown Children’s. “It was found to give kids strong protection against COVID-19, including against the Delta variant. Children who are vaccinated may have some side effects (chills, redness and swelling at site injection), which are normal signs that their body is building protection.” Children are advised not to receive the vaccine if: • They are ill at the time of vaccination (fever, shortness of breath, vomiting, diarrhea or acute illness). • They have been diagnosed with COVID-19 in the previous 14 days. • They have a history of significant allergic reaction to any of the ingredients in the vaccine.   About Renown Health Renown Health is the region’s largest not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org.

Read More About The Greatest Gift of All? A Fully Vaccinated Family!

After a year of possibly delayed colorectal cancer screenings due to theCOVID-19 pandemic, it’s more important than ever to raise awareness for colorectal cancer. March is National Colorectal Cancer Awareness Month- a time to raise awareness for colorectal cancer and the importance of routine, life-saving screenings. Renown invites the community to join the organization in helping put an end to the preventable disease.  Blue is the designated color to bring awareness to colorectal cancer and those impacted by it. The iconic “LOVE” sculpture at the main entrance of Renown Regional Medical Center located at 1155 Mill Street in Reno, Nev. will shine brightly in blue each evening in March, serving as a visual reminder to passersby to schedule a colorectal screening. The Colorectal Cancer Alliance estimates 149,500 new cases of colon cancer will present in 2021 alone. While colorectal cancer may be the second deadliest cancer in men and women combined, it is also one of the most preventable cancers with screenings.  “Unfortunately, due to the COVID-19 pandemic, there’s been a decline in colorectal screenings nationwide,” said Tony Slonim, MD, DrPH, President and CEO of Renown Health. “We know early detection is key in preventing the spread of any cancer, and with regular screenings, we know colorectal cancer is easily detectable and treatable. As a cancer survivor, I know how important it is to get back on track with regular screenings and preventive care. Making your health a priority now will help you experience a healthier and brighter tomorrow.”   “We invite the community to join us at Renown in spreading awareness about colorectal cancer and its prevention,” said Susan Cox, director of cancer services at the Renown Institute for Cancer. “It takes all of us to put an end to colorectal cancer. If you’re up to date on your screenings, remind a loved one to schedule their next screening--as your reminder may have the power to save their life.” “Colorectal cancer usually forms from precancerous polyps, or abnormal growths, in the colon or rectum, which can become malignant without presenting any symptoms. Screening tests like stool tests, colonoscopies, and others can detect these precancerous polyps, so they can be removed by a physician before turning into cancer. Screening tests can also find colorectal cancer early, resulting in better treatment outcomes,” says Christos Galanopoulos, M.D., MBA, oncologic surgeon, VP Renown Health & Chair of Surgery for Renown Health.   Dr. Galanopoulos adds, “Most people begin screening for colorectal cancer after turning 50. However, some individuals may begin screenings earlier if they have an increased risk of colorectal cancer, such as a family history with the disease. Regardless of one’s personal or family history of colorectal cancer, it’s important to talk to your doctor about the right time to begin your screenings.”  Max J. Coppes, MD, Cancer Center Director, Renown Institute for Cancer adds, “While routine screenings are the only way to determine colorectal health, some healthy habits may reduce your risk for colorectal cancer. These factors include maintaining a healthy weight, being physically active, eating a diet rich in fresh fruits, vegetables and whole grains, limiting alcohol intake and not smoking.”  Dr. Coppes explains that, “1 in 500 Americans will test positive for Lynch Syndrome, a genetic condition that raises your risk of colon cancer, endometrial cancer, and other cancers. It is also known as hereditary nonpolyposis colorectal cancer. People with Lynch Syndrome are also susceptible to colon polyps at a younger age. The Healthy Nevada Project research team is looking at the occurrence of important inherited genetic variants in our population that increase the risk of certain diseases. These include Familial Hypercholesterolemia, Hereditary Breast and Ovarian Cancer Syndrome and Lynch Syndrome.” To enroll in The Healthy Nevada Project, a clinical study (saliva test) offering the opportunity to learn about your ancestry, diet insights and genetic risks linked to heart disease and certain cancers, including prevention strategies, at no cost, enroll here. For a limited time, Nevada residents may request a free DNA test kit that will be shipped to your home.  Renown experts encourage every adult to talk to their doctor about their colorectal cancer risk and screening options. Those looking to schedule a screening or establish care with a Renown primary care provider are invited to call us at 775-691-7308 or visit our website for more information.     About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Heath and Neurosciences. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®.

Read More About Awareness Saves Lives: Renown Goes Blue for Colorectal Cancer Awareness Month

Both organizations have a long history of community support, a reputation for exceptionally-trained physician and provider teams, innovative approaches that have improved access and convenience, superior levels of clinical quality and service, and a commitment to making health care more affordable.    “What an important day for orthopedic care in our community! This partnership brings together two organizations that have the vision to elevate care, expertise and innovation in orthopedics and sports medicine,” said Renny Uppal, MD, ROC President and Chairman. ”We are excited to help usher in the next generation of orthopedic care for our community.”    “We have worked closely with the Reno Orthopedic Clinic and its team of caregivers for a long time, and we recognize the excellent quality of care and compassion they provide to their patients,” said Tony Slonim, MD, D.Ph., Renown’s President & CEO. “Given our mutual interests in advancing high-quality and high-value care, this partnership expands capabilities, enhances access and affordability, improves the health of our community and establishes a new premier destination for orthopedics and sports medicine, right here in northern Nevada.”   This partnership for orthopedic health care is the result of the unique collaborative relationship between Renown Health, Reno’s only not-for-profit health care system; and Reno Orthopedic Clinic, an independently-owned and operated, private multi-specialty orthopedic practice. This partnership brings together three key elements to serve the community with enhanced orthopedic care that includes:   A seamless patient journey. With the patient at the center, ROC and Renown will co-design the ideal orthopedic patient care experience, provide consistent clinical care pathways and a seamless experience.   Increased value for the patient. Working collaboratively, ROC and Renown healthcare providers will work on behalf of the patient to deliver orthopedic care. Both organizations are leading the way in providing exceptional care teams to increase value, efficiency, improve outcomes and better manage the total cost of care for patients.  A new level of convenience. Over the next year, ROC or Renown patients will be able to schedule appointments online, view radiology and lab results online, send a message to their provider or view documentation of procedures, surgeries and medications, 24 hours a day on Renown’s Epic MyChart electronic medical record, which is available via smart phone app or computer. This new technology will enhance communication between patients and their medical teams, reduce delays and increase efficiency.  “Both ROC and Renown have a focus on offering well-coordinated, innovative and efficient care, and an improved patient experience. There is great potential to improve quality, accessibility and affordability of orthopedic care for our community. We look forward to improving care together,” said Eric Boyden, MD, a physician with the ROC Center for Joint Replacement.   “Delivering high-quality, cost-effective services in the communities where our patients live is a fundamental part of Renown Health’s strategy. Traditionally, orthopedic surgeries were performed in hospitals, but advancements in technology, anesthesia and pain control now allow physicians to perform certain procedures in an outpatient site, or an ambulatory surgical center which can be a more convenient and cost-effective option, said Erik Olson, CEO of Renown Regional Medical Center. “Our community is growing and we are seeing more complex care needs. Renown is excited to invest and expand the range of outpatient surgical services we have available.”  "Through this partnership, patients from throughout the region will visit us for the most advanced technologies in orthopedic care, and experience the remarkable customer service we provide,” says Lisa Mead, ROC CEO. “We are excited that this partnership will allow our orthopedic surgeons to perform surgeries in a range of settings, and to do what is best for the patient, be that in a hospital or an outpatient site.”   Reno Orthopedic Clinic, in response to the tremendous growth in the region, has been working over the last five years to create the $54 million dollar ROC Institute for Musculoskeletal Health, a new facility being built in downtown Reno. The combined strength of the new partnership will further develop the capabilities for this Institute which features a surgery center, advanced imaging center, clinical offices, physical therapy, a post-operative recovery center and the Chiron Center – a bio skills lab and education center, offering specialized training for future healthcare providers. The facility is on schedule to open at 555 North Arlington Avenue in winter 2020.   A member of the northern Nevada community for over 60 years, providing high-quality orthopedic care across eight offices, Reno Orthopedic Clinic brings to the relationship 31 physicians, 20 advanced practitioners, and 15 physical and occupational therapists specializing in orthopedic surgery, physical medicine and rehabilitation, sports medicine and coverage in nearly every orthopedic subspecialty.   Renown Regional Medical Center is home to one of the nation’s busiest Trauma Centers, accredited by the American College of Surgeons, caring for thousands of people, the vast majority requiring some level of orthopedic care. With more than 150 years of excellence in orthopedics, the Joint Commission has given their Gold Seal of Approval® accreditation to Renown for Total Knee Replacement, Total Hip Replacement and Total Shoulder Replacement. US News & World Report ranks Renown South Meadows Medical Center as “High Performing” for Knee Replacement and Hip Replacement.  "With all of the pieces in place – top quality orthopedic specialty providers and one of the busiest trauma programs in the nation – we expect the ROC Institute for Musculoskeletal Health Center for Orthopedic Medicine will be a gift to those who live, work and play here in Nevada," said Ms. Mead.       www.renoortho.com/ www.renown.org

Read More About Reno Orthopedic Clinic and Renown Partner to Enhance Orthopedic Care for Northern Nevada

Expanded test processing capabilities is resulting in faster test results, lessening the load on the state lab, and helping keep patients, care providers and the community safe. Renown Health announced today that its in-house laboratory is now able to process up to 500 COVID-19 tests for hospital patients and care providers each day. The organization has invested in expanded test processing capabilities to better serve the community amid the coronavirus pandemic, and to increase testing available across the state. Next month, Renown anticipates continuing to further expand testing capacity and doubling its capacity to be able to provide 1,000 tests per day in preparation for the continued response to the pandemic. “The COVID-19 pandemic is not going away- it is still with us. I am concerned by the number of new cases and hospitalizations we are seeing across northern Nevada. We must do more testing. We need broader capabilities around making sure we have broad-scale surge testing available, so we can help people identify if they have COVID-19 or not,” said Tony Slonim, MD, DrPH, Renown’s President & CEO. “If I could test 60,000 people in northern Nevada for COVID-19, like we did for the Healthy Nevada Project, we could better understand with data and facts the proportion of people who actually have COVID-19 versus those that just have the sniffles and a cold.” Launched in 2016, the Healthy Nevada Project https://healthynv.org/ is a community-based population study where free genetic testing is provided to thousands of Nevadans to learn about the health of the community and each person’s genetic risks. As of Tuesday, 2,286 people in northern Nevada have been tested, and positive cases were nearing 700. Seventy four people in northern Nevada have died; 1,526 have recovered. https://www.washoecounty.us/ Dr. Slonim says it would help him and others make important decisions and plans for coronavirus with evidence. He wants to be able to test many more individuals across northern Nevada. “Testing is pivotal upstream, so you can prevent consequences downstream,” said Dawn D. Ahner, DSc, FACHE, Chief Operating Officer – Renown Acute Services. “By processing our own tests, we’ve reduced the turnaround to receive results to just 12-24 hours, which will have a profoundly positive impact on our community, and lightens the load on the State lab. “Testing is an incredibly important tool in our fight against coronavirus,” said Tim Stephens, vice president of ancillary services. “There's no 100% perfect test, however, the PCR tests are so incredibly sensitive, that when done perfectly, have a very low false-positive rate. Certified labs like Renown’s use a number of procedures to reduce the risk of false test results.” “The expansion of our lab’s new testing capabilities during this time is a testament to the innovative and important work being done here at Renown,” said Erik Olson, CEO of Renown Regional Medical Center. “Throughout the pandemic, our ancillary team, which includes services like laboratory, radiology and pharmacy, has been quick to adapt to the needs of our patients and our community. I am pleased that we are able to generate critical test results for patients and providers as we continue the fight against COVID-19 and go the extra mile for safety.”   Going the extra mile for safety As an added safety measure, acute hospital patients; patients preparing for surgery, and care providers who may have come into contact with those positive for COVID-19, are among those that receive mandatory PCR testing from Renown at this time. For patients receiving hospital care, these tests help determine if patients should be placed in a designated area of the hospital to mitigate the risk of transmission to those not infected. Furthermore, all surgery patients are tested ahead of their surgery and self-quarantine prior to their surgical procedure at Renown Regional Medical Center and Renown South Meadows Medical Center. How do PCR tests work? PCR tests use a sample of mucus typically taken from a person's nose or throat. The test looks for the genetic material of the coronavirus, using a technology called PCR to detect if the viral genetic material is present. Those actively infected with the virus will show the existence of that material. Individuals who think they should be tested for COVID-19 are encouraged to call their medical provider or contact the Washoe County Health District at 775-328-2427 for a risk assessment. For up-to-date information on Renown’s approach to keeping our community safe, visit our website at renown.org/covid-19/.   Please see b-roll for this story here.     About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, Renown Children’s Hospital, Renown Rehabilitation Hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to continually improve the care and the health of our community. For more information, visit renown.org.

Read More About Renown Health In-House Lab Now Processing COVID-19 Tests for Patients and Care Providers